Transcriptomic profiles and 5-year results from the randomized CLL14 study of venetoclax plus obinutuzumab versus chlorambucil plus obinutuzumab in chronic lymphocytic leukemiaOthman Al‐Sawaf, Kirsten Fischer, Yoonha Choi et al.|Nature Communications|2023Cited by 94
Author Correction: Transcriptomic profiles and 5-year results from the randomized CLL14 study of venetoclax plus obinutuzumab versus chlorambucil plus obinutuzumab in chronic lymphocytic leukemiaOthman Al‐Sawaf, Kirsten Fischer, Can Zhang et al.|Nature Communications|2023Cited by 3